Dr Yousuf al-Maslamani, medical director of Hamad General Hospital (HGH) and director of the Qatar Center for Organ Transplantation at Hamad Medical Corporation (HMC), has been elected vice president of the Middle East Society for Organ Transplantation (Mesot
) for a two-year term.
Joel Mesot is a distinguished scientist who has also demonstrated impressive abilities in the management of modern science and research institutions.
As PSI director Joel Mesot moved the institute forward to become an internationally renowned user lab and research institute.
Mesot received the ETH Zurichs Latsis Prize for excellence in research.
This appointment was confirmed during the recent 14th Mesot Congress meeting in
Dr al-Maslamani was also awarded by Mesot for his exemplary leadership in developing Qatar's internationally recognised model for organ donation and transplantation.
"I am honoured to have been elected by an eminent group of experts in the field of organ transplantation to represent not only Qatar but also other GCC countries on Mesot's executive board for the next four years.
At the Mesot Congress, the HMC delegation presented four scientific lectures on different subjects including 'Doha model for organ donation, kidney transplantation and liver transplantation'.
HMC also won a silver medal in table tennis at this year's Mesot games.
Speaking to Khaleej Times on the sidelines of the announcement of the 13th Congress of the Middle East Society of Organ Transplantation (MESOT), which will be held on December 12-15, Dr Al Obaidli said the move was "progressing".
In parallel to the MESOT Congress, the fourth Middle East Transplant Games (METG) will be holding its inaugural event at the Armed Forces Officers Club on December 14-15.
QNA Doha Dr Yousuf al Maslamani, the Medical Director of Hamad General Hospital (HGH) and Director of the Qatar Center for Organ Transplantation at HMC, has been elected Vice President of the Middle East Society for Organ Transplantation (MESOT
) for a two-year term until 2020.